PAPOLA-mediated hyperactive polyadenylation promotes leukemogenesis and leukemia stem cell self-renewal through metabolic reprogramming.
Blocking a specific protein called PAPOLA may help prevent leukemia stem cells from self-renewing, offering a potential new treatment target.
PAPOLA-driven hyperactive polyadenylation promotes AML leukemia stem cell self-renewal via the GSTM2-HNE-DLD metabolic axis; cordycepin inhibition of PAPOLA suppresses leukemogenesis. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- mechanistic study with primary AML samples, cell lines, and mouse models
- Category
- hematologic_malignancies
- Maturity
- Exploratory
- Journal
- Nat Cancer
Why it surfaced
Nature Cancer publication revealing a novel oncogenic mechanism—hyperactive polyadenylation linking RNA processing to AML cancer metabolism—with identification of a druggable PAPOLA-GSTM2-HNE-DLD axis.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.